North America Interoperability Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA INTEROPERABILITY MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 MARKET END USER COVERAGE GRID

2.1 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 INDUSTRY INSIGHTS – NORTH AMERICA INTEROPERABILITY MARKET

4.1.1 MICRO AND MACRO ECONOMIC FACTORS

4.1.2 PENETRATION AND GROWTH PROSPECT MAPPING

4.1.3 KEY PRICING STRATEGIES

4.1.4 ANALYSIS AND RECOMMENDATION

4.2 HEALTHCARE TARIFFS IMPACT ANALYSIS

4.2.1 OVERVIEW

4.2.2 TARIFF STRUCTURES

4.2.2.1 NORTH AMERICA VS. REGIONAL TARIFF STRUCTURES

4.2.2.2 UNITED STATES: MEDICARE/MEDICAID TARIFF POLICIES, CMS PRICING MODELS

4.2.2.3 EUROPEAN UNION: CROSS-BORDER TARIFF REGULATIONS, REIMBURSEMENT POLICIES

4.2.2.4 ASIA-PACIFIC: GOVERNMENT-IMPOSED TARIFFS ON IMPORTED MEDICAL PRODUCTS

4.2.2.5 EMERGING MARKETS: CHALLENGES IN TARIFF IMPLEMENTATION

4.2.3 PHARMACEUTICAL TARIFFS AND TRADE BARRIERS

4.2.3.1 IMPORT DUTIES ON PRESCRIPTION DRUGS VS. GENERICS

4.2.3.2 IMPACT ON DRUG AFFORDABILITY AND ACCESS

4.2.3.3 KEY TRADE AGREEMENTS AFFECTING PHARMACEUTICAL TARIFFS

4.2.4 IMPACT OF HEALTHCARE TARIFFS ON PROVIDERS AND PATIENTS

4.2.4.1 COST BURDEN ON HOSPITALS AND HEALTHCARE FACILITIES

4.2.4.2 EFFECT ON PATIENT AFFORDABILITY AND INSURANCE COVERAGE

4.2.4.3 TARIFFS AND THEIR ROLE IN MEDICAL TOURISM

4.2.5 TRADE AGREEMENTS AND HEALTHCARE TARIFFS

4.2.5.1 WTO REGULATIONS ON HEALTHCARE TARIFFS

4.2.5.2 IMPACT OF TRADE WARS ON THE HEALTHCARE SUPPLY CHAIN

4.2.5.3 ROLE OF FREE TRADE AGREEMENTS (FTAS) IN REDUCING TARIFFS

4.2.5.4 IMPACT OF TARIFFS ON HEALTHCARE COSTS AND ACCESSIBILITY

4.2.5.5 IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR

4.3 COMPANY EVALUATION QUADRANT

5 REGULATORY FRAMEWORK

5.1 REGULATORY APPROVAL PROCESS

5.2 GEOGRAPHIES’ EASE OF REGULATORY APPROVAL

5.3 REGULATORY APPROVAL PATHWAYS

5.4 LICENSING AND REGISTRATION

5.5 POST-MARKETING SURVEILLANCE

5.6 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RAPID DIGITALIZATION OF HEALTHCARE AND RISING HEALTHCARE IT SPENDING ACROSS APAC

6.1.2 STRONG GOVERNMENT INITIATIVES AND NATIONAL EHR/EMR PROGRAMS

6.1.3 ACCELERATING SHIFT TOWARD VALUE-BASED CARE AND POPULATION HEALTH MANAGEMENT

6.1.4 THE RAPID EXPANSION OF TELEHEALTH, REMOTE PATIENT MONITORING

6.2 RESTRAINTS

6.2.1 HIGH UP-FRONT IMPLEMENTATION AND INTEGRATION COSTS FOR HOSPITALS AND CLINICS

6.2.2 FRAGMENTED REGULATORY AND REIMBURSEMENT LANDSCAPES ACROSS APAC COUNTRIES

6.3 OPPORTUNITIES

6.3.1 RISING DEMAND FOR INTEROPERABLE EMR PLATFORMS SUPPORTING HEALTH INFORMATION EXCHANGE

6.3.2 GROWING ADOPTION OF SOFTWARE-AS-A-SERVICE (SAAS) AND CLOUD-BASED EMR SOLUTIONS

6.3.3 EXPANSION OF INTEROPERABILITY SOLUTIONS FOR AI-DRIVEN HEALTHCARE PLATFORMS

6.4 CHALLENGES

6.4.1 ENSURING DATA PRIVACY, CYBERSECURITY, AND COMPLIANCE WITH COUNTRYSPECIFIC HEALTH DATA PROTECTION REGULATIONS

6.4.2 INTEROPERABILITY ISSUES DUE TO DIVERSE DATA STANDARDS, CODING SYSTEMS, AND VENDOR ECOSYSTEMS

7 NORTH AMERICA INTEROPERABILITY MARKET, BY COMPONENT TYPE

7.1 OVERVIEW

7.2 SOFTWARE

7.2.1 SOFTWARE IN INTEROPERABILITY MARKET, BY TYPE

7.2.1.1 INTEGRATION & INTEROPERABILITY PLATFORMS

7.2.1.1.1 INTEGRATION & INTEROPERABILITY PLATFORMS IN INTEROPERABILITY MARKET, BY TYPE

7.2.1.1.1.1 ENTERPRISE INTEGRATION ENGINES

7.2.1.1.1.2 MIDDLEWARE PLATFORMS

7.2.1.1.1.3 INTERFACE ENGINES

7.2.1.1.1.4 API MANAGEMENT PLATFORMS

7.2.1.1.1.5 DATA EXCHANGE & MESSAGING SOFTWARE

7.2.1.2 HEALTH INFORMATION EXCHANGE (HIE) SOFTWARE

7.2.1.2.1 HEALTH INFORMATION EXCHANGE (HIE) SOFTWARE IN INTEROPERABILITY MARKET, BY INSTALLATION TYPE

7.2.1.2.1.1 PUBLIC / GOVERNMENT-LED HIE PLATFORMS

7.2.1.2.1.2 REGIONAL HIE (RHIO) PLATFORMS

7.2.1.2.1.3 PRIVATE HIE PLATFORMS

7.2.1.2.1.4 NATIONAL HEALTH DATA EXCHANGE PLATFORMS

7.2.1.2.1.5 HEALTH INFORMATION EXCHANGE (HIE) SOFTWARE (GENERIC / PLATFORM-LEVEL)

7.2.1.3 STANDARDS-BASED & PROTOCOL INTEROPERABILITY SOFTWARE

7.2.1.3.1 STANDARDS-BASED & PROTOCOL INTEROPERABILITY SOFTWARE IN INTEROPERABILITY MARKET, BY TYPE

7.2.1.3.1.1 HL7 V2 / V3 MESSAGING SOFTWARE

7.2.1.3.1.2 FHIR-BASED INTEROPERABILITY SOFTWARE

7.2.1.3.1.3 X12 / EDI TRANSACTION SOFTWARE

7.2.1.3.1.4 DICOM INTEROPERABILITY SOFTWARE

7.2.1.4 EMR / EHR INTEROPERABILITY SOFTWARE

7.2.1.4.1 EMR / EHR INTEROPERABILITY SOFTWARE IN INTEROPERABILITY MARKET, BY INSTALLATION TYPE

7.2.1.4.1.1 EMR-TO-EMR INTEROPERABILITY

7.2.1.4.1.2 EMR-TO-HIS INTEROPERABILITY

7.2.1.4.1.3 EMR-TO-RIS / PACS INTEROPERABILITY

7.2.1.4.1.4 EMR-TO-LIS INTEROPERABILITY

7.2.1.4.1.5 EMR / EHR INTEROPERABILITY SOFTWARE (GENERIC / PLATFORM-LEVEL)

7.2.1.5 DATA, IDENTITY & SEMANTIC INTEROPERABILITY SOFTWARE

7.2.1.5.1 DATA, IDENTITY & SEMANTIC INTEROPERABILITY SOFTWARE IN INTEROPERABILITY MARKET, BY INSTALLATION TYPE

7.2.1.5.1.1 DATA MANAGEMENT & NORMALIZATION SOFTWARE

7.2.1.5.1.2 DATA MAPPING & TRANSFORMATION TOOLS

7.2.1.5.1.3 MASTER PATIENT INDEX (MPI) SOFTWARE

7.2.1.5.1.4 TERMINOLOGY MANAGEMENT SOFTWARE

7.2.1.5.1.5 CLINICAL DATA NORMALIZATION SOFTWARE

7.2.1.6 MEDICAL DEVICE & CONNECTED CARE INTEROPERABILITY SOFTWARE

7.2.1.6.1 MEDICAL DEVICE & CONNECTED CARE INTEROPERABILITY SOFTWARE IN INTEROPERABILITY MARKET, BY UV STABILIZATION TECHNOLOGY

7.2.1.6.1.1 MEDICAL DEVICE & IOT INTEROPERABILITY SOFTWARE

7.2.1.6.1.2 BEDSIDE DEVICE INTEGRATION SOFTWARE

7.2.1.6.1.3 IMAGING DEVICE INTEROPERABILITY

7.2.1.6.1.4 WEARABLE & REMOTE MONITORING INTEGRATION

7.2.1.6.1.5 CONNECTED CARE PLATFORM INTEGRATIONS

7.2.2 SOFTWARE IN INTEROPERABILITY MARKET, BY REGION

7.2.2.1 NORTH AMERICA

7.2.2.2 EUROPE

7.2.2.3 ASIA-PACIFIC

7.2.2.4 SOUTH AMERICA

7.2.2.5 MIDDLE EAST & AFRICA

7.3 SERVICES

7.3.1 SERVICE IN INTEROPERABILITY MARKET, BY TYPE

7.3.1.1 SYSTEM INTEGRATION SERVICES

7.3.1.1.1 SYSTEM INTEGRATION SERVICES IN INTEROPERABILITY MARKET, BY TYPE

7.3.1.1.1.1 IMPLEMENTATION & INTEGRATION SERVICES

7.3.1.1.1.2 CUSTOM INTERFACE DEVELOPMENT

7.3.1.1.1.3 LEGACY SYSTEM MODERNIZATION

7.3.1.1.1.4 DATA MIGRATION SERVICES

7.3.1.1.1.5 PLATFORM DEPLOYMENT SERVICES

7.3.1.2 MANAGED SERVICES

7.3.1.2.1 MANAGED SERVICES IN INTEROPERABILITY MARKET, BY TYPE

7.3.1.2.1.1 MANAGED INTEGRATION SERVICES

7.3.1.2.1.2 CLOUD-MANAGED INTEROPERABILITY SERVICES

7.3.1.2.1.3 MANAGED HIE OPERATIONS

7.3.1.2.1.4 MANAGED API SERVICES

7.3.1.3 PROFESSIONAL SERVICES

7.3.1.3.1 PROFESSIONAL SERVICES IN INTEROPERABILITY MARKET, BY TYPE

7.3.1.3.1.1 CONSULTING & STRATEGY SERVICES

7.3.1.3.1.2 WORKFLOW & SYSTEM ASSESSMENT

7.3.1.3.1.3 REGULATORY & COMPLIANCE CONSULTING

7.3.1.4 SUPPORT & MAINTENANCE SERVICES

7.3.1.4.1 SUPPORT & MAINTENANCE SERVICES IN INTEROPERABILITY MARKET, BY TYPE

7.3.1.4.1.1 TECHNICAL SUPPORT

7.3.1.4.1.2 SYSTEM MAINTENANCE

7.3.1.4.1.3 VERSION UPGRADES

7.3.1.4.1.4 PERFORMANCE OPTIMIZATION

7.3.2 SERVICES IN INTEROPERABILITY MARKET, BY REGION

7.3.2.1 NORTH AMERICA

7.3.2.2 EUROPE

7.3.2.3 ASIA-PACIFIC

7.3.2.4 SOUTH AMERICA

7.3.2.5 MIDDLE EAST & AFRICA

8 NORTH AMERICA INTEROPERABILITY MARKET, BY INTEROPERABILITY LEVEL

8.1 OVERVIEW

8.1 FOUNDATIONAL INTEROPERABILITY

8.1.1 FOUNDATIONAL INTEROPERABILITY IN INTEROPERABILITY MARKET, BY TYPE

8.1.1.1 SECURE DATA TRANSMISSION

8.1.1.2 BASIC DATA EXCHANGE

8.1.2 FOUNDATIONAL INTEROPERABILITY IN INTEROPERABILITY MARKET, BY REGION

8.1.2.1 NORTH AMERICA

8.1.2.2 EUROPE

8.1.2.3 ASIA-PACIFIC

8.1.2.4 SOUTH AMERICA

8.1.2.5 MIDDLE EAST & AFRICA

8.2 STRUCTURAL INTEROPERABILITY

8.2.1 STRUCTURAL INTEROPERABILITY IN INTEROPERABILITY MARKET, BY TYPE

8.2.1.1 STRUCTURED MESSAGING FRAMEWORKS

8.2.1.2 STANDARDIZED DATA FORMATTING

8.2.2 STRUCTURAL INTEROPERABILITY IN INTEROPERABILITY MARKET, BY REGION

8.2.2.1 NORTH AMERICA

8.2.2.2 EUROPE

8.2.2.3 ASIA-PACIFIC

8.2.2.4 SOUTH AMERICA

8.2.2.5 MIDDLE EAST & AFRICA

8.3 ORGANIZATIONAL INTEROPERABILITY

8.3.1 ORGANISATIONAL INTEROPERABILITY IN INTEROPERABILITY MARKET, BY APPLICATION

8.3.1.1 CROSS-ORGANIZATION CARE COORDINATION

8.3.1.2 POLICY & GOVERNANCE INTEGRATION

8.3.1.3 WORKFLOW ALIGNMENT

8.3.2 ORGANIZATIONAL INTEROPERABILITY IN INTEROPERABILITY MARKET, BY REGION

8.3.2.1 NORTH AMERICA

8.3.2.2 EUROPE

8.3.2.3 ASIA-PACIFIC

8.3.2.4 SOUTH AMERICA

8.3.2.5 MIDDLE EAST & AFRICA

8.4 SEMANTIC INTEROPERABILITY

8.4.1 SEMENTIC INTEROPERABILITY IN INTEROPERABILITY MARKET, BY PRODUCT

8.4.1.1 CLINICAL TERMINOLOGY MAPPING

8.4.1.2 CONTEXT-AWARE DATA INTERPRETATION

8.4.1.3 AI-ENABLED SEMANTIC MAPPING

8.4.2 ORGANIZATIONAL INTEROPERABILITY IN INTEROPERABILITY MARKET, BY REGION

8.4.2.1 NORTH AMERICA

8.4.2.2 EUROPE

8.4.2.3 ASIA-PACIFIC

8.4.2.4 SOUTH AMERICA

8.4.2.5 MIDDLE EAST & AFRICA

9 NORTH AMERICA INTEROPERABILITY MARKET, BY DEPLOYMENT MODEL, 2018-2033 (USD THOUSAND)

9.1 OVERVIEW

9.2 ON-PREMISE

9.3 CLOUD-BASED

9.4 EDGE & GATEWAY-BASED DEPLOYMENT

9.4.1 NORTH AMERICA ON-PREMISES IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.1.1 HOSPITAL-BASED DEPLOYMENTS

9.4.1.2 GOVERNMENT HEALTHCARE FACILITIES

9.4.2 NORTH AMERICA ON-PREMISE IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.4.2.1 NORTH AMERICA

9.4.2.2 EUROPE

9.4.2.3 ASIA-PACIFIC

9.4.2.4 SOUTH AMERICA

9.4.2.5 MIDDLE EAST & AFRICA

9.4.3 NORTH AMERICA CLOUD-BASED IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.3.1 HYBRID CLOUD

9.4.3.2 PRIVATE CLOUD

9.4.3.3 PUBLIC CLOUD

9.4.4 NORTH AMERICA CLOUD-BASED IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.4.4.1 NORTH AMERICA

9.4.4.2 EUROPE

9.4.4.3 ASIA-PACIFIC

9.4.4.4 SOUTH AMERICA

9.4.4.5 MIDDLE EAST & AFRICA

9.4.5 NORTH AMERICA EDGE & GATEWAY-BASED DEPLOYMENT IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.5.1 DEVICE-LEVEL GATEWAYS

9.4.5.2 LOCAL DATA EXCHANGE NODES

9.4.6 NORTH AMERICA EDGE & GATEWAY-BASED DEPLOYMENT IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.4.6.1 NORTH AMERICA

9.4.6.2 EUROPE

9.4.6.3 ASIA-PACIFIC

9.4.6.4 SOUTH AMERICA

9.4.6.5 MIDDLE EAST & AFRICA

9.4.7 NORTH AMERICA INTEROPERABILITY MARKET, BY COMPONENT TYPE, 2018-2033 (USD THOUSAND)

9.4.7.1 SOFTWARE

9.4.7.2 SERVICES

9.4.8 NORTH AMERICA SOFTWARE IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.8.1 INTEGRATION & INTEROPERABILITY PLATFORMS

9.4.8.2 HEALTH INFORMATION EXCHANGE (HIE) SOFTWARE

9.4.8.3 STANDARDS-BASED & PROTOCOL INTEROPERABILITY SOFTWARE

9.4.8.4 EMR / EHR INTEROPERABILITY SOFTWARE

9.4.8.5 DATA, IDENTITY & SEMANTIC INTEROPERABILITY SOFTWARE

9.4.8.6 MEDICAL DEVICE & CONNECTED CARE INTEROPERABILITY SOFTWARE

9.4.9 NORTH AMERICA INTEGRATION & INTEROPERABILITY PLATFORMS IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.9.1 ENTERPRISE INTEGRATION ENGINES

9.4.9.2 MIDDLEWARE PLATFORMS

9.4.9.3 INTERFACE ENGINES

9.4.9.4 API MANAGEMENT PLATFORMS

9.4.9.5 DATA EXCHANGE & MESSAGING SOFTWARE

9.4.10 NORTH AMERICA HEALTH INFORMATION EXCHANGE (HIE) SOFTWARE IN INTEROPERABILITY MARKET, BY INSTALLATION TYPE, 2018-2033 (USD THOUSAND)

9.4.10.1 PUBLIC / GOVERNMENT-LED HIE PLATFORMS

9.4.10.2 REGIONAL HIE (RHIO) PLATFORMS

9.4.10.3 PRIVATE HIE PLATFORMS

9.4.10.4 NATIONAL HEALTH DATA EXCHANGE PLATFORMS

9.4.10.5 HEALTH INFORMATION EXCHANGE (HIE) SOFTWARE (GENERIC / PLATFORM-LEVEL)

9.4.11 NORTH AMERICA STANDARDS-BASED & PROTOCOL INTEROPERABILITY SOFTWARE IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.11.1 HL7 V2 / V3 MESSAGING SOFTWARE

9.4.11.2 FHIR-BASED INTEROPERABILITY SOFTWARE

9.4.11.3 X12 / EDI TRANSACTION SOFTWARE

9.4.11.4 DICOM INTEROPERABILITY SOFTWARE

9.4.12 NORTH AMERICA EMR / EHR INTEROPERABILITY SOFTWAREG IN INTEROPERABILITY MARKET, BY INSTALLATION TYPE, 2018-2033 (USD THOUSAND)

9.4.12.1 EMR-TO-EMR INTEROPERABILITY

9.4.12.2 EMR-TO-HIS INTEROPERABILITY

9.4.12.3 EMR-TO-RIS / PACS INTEROPERABILITY

9.4.12.4 EMR-TO-LIS INTEROPERABILITY

9.4.12.5 EMR / EHR INTEROPERABILITY SOFTWARE (GENERIC / PLATFORM-LEVEL)

9.4.13 NORTH AMERICA DATA, IDENTITY & SEMANTIC INTEROPERABILITY SOFTWARE IN INTEROPERABILITY MARKET, BY INSTALLATION TYPE, 2018-2033 (USD THOUSAND)

9.4.13.1 DATA MANAGEMENT & NORMALIZATION SOFTWARE

9.4.13.2 DATA MAPPING & TRANSFORMATION TOOLS

9.4.13.3 MASTER PATIENT INDEX (MPI) SOFTWARE

9.4.13.4 TERMINOLOGY MANAGEMENT SOFTWARE

9.4.13.5 CLINICAL DATA NORMALIZATION SOFTWARE

9.4.14 NORTH AMERICA MEDICAL DEVICE & CONNECTED CARE INTEROPERABILITY SOFTWARE IN INTEROPERABILITY MARKET, BY UV STABILIZATION TECHNOLOGY, 2018-2033 (USD THOUSAND)

9.4.14.1 MEDICAL DEVICE & IOT INTEROPERABILITY SOFTWARE

9.4.14.2 BEDSIDE DEVICE INTEGRATION SOFTWARE

9.4.14.3 IMAGING DEVICE INTEROPERABILITY

9.4.14.4 WEARABLE & REMOTE MONITORING INTEGRATION

9.4.14.5 CONNECTED CARE PLATFORM INTEGRATIONS

9.4.15 NORTH AMERICA SOFTWARE IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.4.15.1 NORTH AMERICA

9.4.15.2 EUROPE

9.4.15.3 ASIA-PACIFIC

9.4.15.4 SOUTH AMERICA

9.4.15.5 MIDDLE EAST & AFRICA

9.4.16 NORTH AMERICA SERVICE IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.16.1 SYSTEM INTEGRATION SERVICES

9.4.16.2 MANAGED SERVICES

9.4.16.3 PROFESSIONAL SERVICES

9.4.16.4 SUPPORT & MAINTENANCE SERVICES

9.4.17 NORTH AMERICA SYSTEM INTEGRATION SERVICES IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.17.1 IMPLEMENTATION & INTEGRATION SERVICES

9.4.17.2 CUSTOM INTERFACE DEVELOPMENT

9.4.17.3 LEGACY SYSTEM MODERNIZATION

9.4.17.4 DATA MIGRATION SERVICES

9.4.17.5 PLATFORM DEPLOYMENT SERVICES

9.4.18 NORTH AMERICA MANAGED SERVICES IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.18.1 MANAGED INTEGRATION SERVICES

9.4.18.2 CLOUD-MANAGED INTEROPERABILITY SERVICES

9.4.18.3 MANAGED HIE OPERATIONS

9.4.18.4 MANAGED API SERVICES

9.4.19 NORTH AMERICA PROFESSIONAL SERVICES IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.19.1 CONSULTING & STRATEGY SERVICES

9.4.19.2 WORKFLOW & SYSTEM ASSESSMENT

9.4.19.3 REGULATORY & COMPLIANCE CONSULTING

9.4.20 NORTH AMERICA SUPPORT & MAINTENANCE SERVICES IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.20.1 TECHNICAL SUPPORT

9.4.20.2 SYSTEM MAINTENANCE

9.4.20.3 VERSION UPGRADES

9.4.20.4 PERFORMANCE OPTIMIZATION

9.4.21 NORTH AMERICA SERVICES IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.4.21.1 NORTH AMERICA

9.4.21.2 EUROPE

9.4.21.3 ASIA-PACIFIC

9.4.21.4 SOUTH AMERICA

9.4.21.5 MIDDLE EAST & AFRICA

9.4.22 NORTH AMERICA INTEROPERABILITY MARKET, BY INTEROPERABILITY LEVEL, 2018-2033 (USD THOUSAND)

9.4.22.1 FOUNDATIONAL INTEROPERABILITY

9.4.22.2 STRUCTURAL INTEROPERABILITY

9.4.22.3 ORGANIZATIONAL INTEROPERABILITY

9.4.22.4 SEMANTIC INTEROPERABILITY

9.4.23 NORTH AMERICA FOUNDATIONAL INTEROPERABILITY IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.23.1 SECURE DATA TRANSMISSION

9.4.23.2 BASIC DATA EXCHANGE

9.4.24 NORTH AMERICA FOUNDATIONAL INTEROPERABILITY IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.4.24.1 NORTH AMERICA

9.4.24.2 EUROPE

9.4.24.3 ASIA-PACIFIC

9.4.24.4 SOUTH AMERICA

9.4.24.5 MIDDLE EAST & AFRICA

9.4.25 NORTH AMERICA STRUCTURAL INTEROPERABILITY IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.25.1 STRUCTURED MESSAGING FRAMEWORKS

9.4.25.2 STANDARDIZED DATA FORMATTING

9.4.26 NORTH AMERICA STRUCTURAL INTEROPERABILITY IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.4.26.1 NORTH AMERICA

9.4.26.2 EUROPE

9.4.26.3 ASIA-PACIFIC

9.4.26.4 SOUTH AMERICA

9.4.26.5 MIDDLE EAST & AFRICA

9.4.27 NORTH AMERICA ORGANISATIONAL INTEROPERABILITY IN INTEROPERABILITY MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)

9.4.27.1 CROSS-ORGANIZATION CARE COORDINATION

9.4.27.2 POLICY & GOVERNANCE INTEGRATION

9.4.27.3 WORKFLOW ALIGNMENT

9.4.28 NORTH AMERICA ORGANIZATIONAL INTEROPERABILITY IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.4.28.1 NORTH AMERICA

9.4.28.2 EUROPE

9.4.28.3 ASIA-PACIFIC

9.4.28.4 SOUTH AMERICA

9.4.28.5 MIDDLE EAST & AFRICA

9.4.29 NORTH AMERICA SEMENTIC INTEROPERABILITY IN INTEROPERABILITY MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)

9.4.29.1 CLINICAL TERMINOLOGY MAPPING

9.4.29.2 CONTEXT-AWARE DATA INTERPRETATION

9.4.29.3 AI-ENABLED SEMANTIC MAPPING

9.4.30 NORTH AMERICA ORGANIZATIONAL INTEROPERABILITY IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.4.30.1 NORTH AMERICA

9.4.30.2 EUROPE

9.4.30.3 ASIA-PACIFIC

9.4.30.4 SOUTH AMERICA

9.4.30.5 MIDDLE EAST & AFRICA

9.4.31 NORTH AMERICA INTEROPERABILITY MARKET, BY DEPLOYMENT MODEL, 2018-2033 (USD THOUSAND)

9.4.31.1 ON-PREMISE

9.4.31.2 CLOUD-BASED

9.4.31.3 EDGE & GATEWAY-BASED DEPLOYMENT

9.4.32 NORTH AMERICA ON-PREMISES IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.32.1 HOSPITAL-BASED DEPLOYMENTS

9.4.32.2 GOVERNMENT HEALTHCARE FACILITIES

9.4.33 NORTH AMERICA ON-PREMISE IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.4.33.1 NORTH AMERICA

9.4.33.2 EUROPE

9.4.33.3 ASIA-PACIFIC

9.4.33.4 SOUTH AMERICA

9.4.33.5 MIDDLE EAST & AFRICA

9.4.34 NORTH AMERICA CLOUD-BASED IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.34.1 HYBRID CLOUD

9.4.34.2 PRIVATE CLOUD

9.4.34.3 PUBLIC CLOUD

9.4.35 NORTH AMERICA CLOUD-BASED IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.4.35.1 NORTH AMERICA

9.4.35.2 EUROPE

9.4.35.3 ASIA-PACIFIC

9.4.35.4 SOUTH AMERICA

9.4.35.5 MIDDLE EAST & AFRICA

9.4.36 NORTH AMERICA EDGE & GATEWAY-BASED DEPLOYMENT IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.36.1 DEVICE-LEVEL GATEWAYS

9.4.36.2 LOCAL DATA EXCHANGE NODES

9.4.37 NORTH AMERICA EDGE & GATEWAY-BASED DEPLOYMENT IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.4.37.1 NORTH AMERICA

9.4.37.2 EUROPE

9.4.37.3 ASIA-PACIFIC

9.4.37.4 SOUTH AMERICA

9.4.37.5 MIDDLE EAST & AFRICA

10 NORTH AMERICA INTEROPERABILITY MARKET , BY ARCHITECTURE MODEL.

10.1 OVERVIEW

10.2 NORTH AMERICA INTEROPERABILITY MARKET, BY ARCHITECTURE MODEL, 2018-2033 (USD THOUSAND)

10.2.1 HYBRID ARCHITECTURE

10.2.2 CENTRALIZED ARCHITECTURE

10.2.3 DECENTRALIZED ARCHITECTURE

10.3 NORTH AMERICA HYBRID ARCHITECTURE IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.3.1 NATIONAL HEALTH DATA REPOSITORIES

10.3.2 CENTRALIZED HIE MODELS

10.4 NORTH AMERICA HYBRID ARCHITECTURE IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

10.4.1 NORTH AMERICA

10.4.2 EUROPE

10.4.3 ASIA-PACIFIC

10.4.4 SOUTH AMERICA

10.4.5 MIDDLE EAST & AFRICA

10.5 NORTH AMERICA CENTRALISED ARCHITECTURE IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.5.1 FEDERATED HEALTH NETWORKS

10.5.2 PEER-TO-PEER DATA EXCHANGE

10.6 NORTH AMERICA CENTRALIZED ARCHITECTURE IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

10.6.1 NORTH AMERICA

10.6.2 EUROPE

10.6.3 ASIA-PACIFIC

10.6.4 SOUTH AMERICA

10.6.5 MIDDLE EAST & AFRICA

10.7 NORTH AMERICA DECENTRALIZED ARCHITECTURE TYPE IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.7.1 CENTRAL INDEX + DISTRIBUTED DATA

10.7.2 REGIONAL–NATIONAL HYBRID MODELS

10.8 NORTH AMERICA CENTRALIZED ARCHITECTURE IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

10.8.1 NORTH AMERICA

10.8.2 EUROPE

10.8.3 ASIA-PACIFIC

10.8.4 SOUTH AMERICA

10.8.5 MIDDLE EAST & AFRICA

11 NORTH AMERICA INTEROPERABILITY MARKET , BY APPLICATION.

11.1 OVERVIEW

11.2 NORTH AMERICA INTEROPERABILITY MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)

11.2.1 CLINICAL APPLICATIONS

11.2.2 ADMINISTRATIVE APPLICATIONS

11.2.3 PUBLIC HEALTH & POPULATION HEALTH

11.2.4 FINANCIAL APPLICATIONS

11.2.5 DIGITAL & VIRTUAL CARE

11.2.6 RESEARCH & ANALYTICS

11.2.7 OTHERS

11.3 NORTH AMERICA CLINICAL APPLICATION IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

11.3.1 DIAGNOSIS & CLINICAL DECISION SUPPORT

11.3.2 TREATMENT PLANNING & COORDINATION

11.3.3 CARE TRANSITIONS & REFERRALS

11.3.4 OTHERS

11.4 NORTH AMERICA CLINICAL APPLICATIONS IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

11.4.1 NORTH AMERICA

11.4.2 EUROPE

11.4.3 ASIA-PACIFIC

11.4.4 SOUTH AMERICA

11.4.5 MIDDLE EAST & AFRICA

11.5 NORTH AMERICA ADMINISTRATIVE APPLICATION IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

11.5.1 PATIENT REGISTRATION & RECORDS

11.5.2 SCHEDULING & RESOURCE MANAGEMENT

11.5.3 OTHERS

11.6 NORTH AMERICA ADMINISTRATIVE APPLICATIONS IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

11.6.1 NORTH AMERICA

11.6.2 EUROPE

11.6.3 ASIA-PACIFIC

11.6.4 SOUTH AMERICA

11.6.5 MIDDLE EAST & AFRICA

11.7 NORTH AMERICA PUBLIC HEALTH & POPULATION HEALTH IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

11.7.1 DISEASE SURVEILLANCE

11.7.2 POPULATION HEALTH ANALYTICS

11.7.3 IMMUNIZATION TRACKING

11.7.4 OTHERS

11.8 NORTH AMERICA PUBLIC HEALTH & POPULATION HEALTH IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

11.8.1 NORTH AMERICA

11.8.2 EUROPE

11.8.3 ASIA-PACIFIC

11.8.4 SOUTH AMERICA

11.8.5 MIDDLE EAST & AFRICA

11.9 NORTH AMERICA FINANCIAL APPLICATION IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

11.9.1 REVENUE CYCLE MANAGEMENT (RCM)

11.9.2 BILLING & CLAIMS MANAGEMENT

11.9.3 INSURANCE VERIFICATION

11.9.4 OTHERS

11.1 NORTH AMERICA FINANCIAL APPLICATIONSH IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

11.10.1 NORTH AMERICA

11.10.2 EUROPE

11.10.3 ASIA-PACIFIC

11.10.4 SOUTH AMERICA

11.10.5 MIDDLE EAST & AFRICA

11.11 NORTH AMERICA DIGITAL & VIRTUAL CARE IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

11.11.1 REMOTE PATIENT MONITORING

11.11.2 TELEHEALTH INTEROPERABILITY

11.11.3 HOME HEALTHCARE INTEGRATION

11.11.4 OTHERS

11.12 NORTH AMERICA DIGITAL & VIRTUAL CARE IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

11.12.1 NORTH AMERICA

11.12.2 EUROPE

11.12.3 ASIA-PACIFIC

11.12.4 SOUTH AMERICA

11.12.5 MIDDLE EAST & AFRICA

11.13 NORTH AMERICA RESEARCH & ANALYTICS TYPE IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

11.13.1 HEALTHCARE ANALYTICS PLATFORMS

11.13.2 REAL-WORLD EVIDENCE (RWE) GENERATION

11.13.3 CLINICAL RESEARCH DATA SHARING

11.13.4 OTHERS

11.14 NORTH AMERICA RESEARCH & ANALYTICS IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

11.14.1 NORTH AMERICA

11.14.2 EUROPE

11.14.3 ASIA-PACIFIC

11.14.4 SOUTH AMERICA

11.14.5 MIDDLE EAST & AFRICA

11.15 NORTH AMERICA OTHERS IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

11.15.1 NORTH AMERICA

11.15.2 EUROPE

11.15.3 ASIA-PACIFIC

11.15.4 SOUTH AMERICA

11.15.5 MIDDLE EAST & AFRICA

12 NORTH AMERICA INTEROPERABILITY MARKET , BY END USER.

12.1 OVERVIEW

12.2 NORTH AMERICA INTEROPERABILITY MARKET, BY END USER, 2018-2033 (USD THOUSAND)

12.2.1 HEALTHCARE PROVIDERS

12.2.2 GOVERNMENT & PUBLIC HEALTH BODIES

12.2.3 HEALTHCARE PAYERS

12.2.4 LIFE SCIENCES & RESEARCH ORGANIZATIONS

12.2.5 PHARMACIES & PHARMACY NETWORKS

12.2.6 PATIENTS & CONSUMER HEALTH PLATFORMS

12.2.7 OTHERS

12.3 NORTH AMERICA HEALTHCARE PROVIDERS IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

12.3.1 HOSPITALS

12.3.2 CLINICS & AMBULATORY CARE CENTERS

12.3.3 SPECIALTY CARE CENTERS

12.3.4 DIAGNOSTIC & IMAGING CENTERS

12.3.5 OTHERS

12.4 NORTH AMERICA HEALTHCARE PROVIDERS IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

12.4.1 NORTH AMERICA

12.4.2 EUROPE

12.4.3 ASIA-PACIFIC

12.4.4 SOUTH AMERICA

12.4.5 MIDDLE EAST & AFRICA

12.5 NORTH AMERICA GOVERNMENT & PUBLIC HEALTH BODIES IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

12.5.1 NATIONAL HEALTH AUTHORITIES

12.5.2 REGIONAL HEALTH DEPARTMENTS

12.5.3 OTHERS

12.6 NORTH AMERICA GOVERNMENT & PUBLIC HEALTH BODIES PROVIDERS IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

12.6.1 NORTH AMERICA

12.6.2 EUROPE

12.6.3 ASIA-PACIFIC

12.6.4 SOUTH AMERICA

12.6.5 MIDDLE EAST & AFRICA

12.7 NORTH AMERICA HEALTHCARE PAYERS IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

12.7.1 INSURANCE COMPANIES

12.7.2 THIRD-PARTY ADMINISTRATORS (TPAS)

12.7.3 OTHERS

12.8 NORTH AMERICA HEALTHCARE PAYERS IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

12.8.1 NORTH AMERICA

12.8.2 EUROPE

12.8.3 ASIA-PACIFIC

12.8.4 SOUTH AMERICA

12.8.5 MIDDLE EAST & AFRICA

12.9 NORTH AMERICA LIFE SCIENCES & RESEARCH ORGANIZATIONS IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

12.9.1 CONTRACT RESEARCH ORGANIZATIONS (CROS)

12.9.2 RESEARCH INSTITUTES

12.9.3 ACADEMIC MEDICAL CENTERS

12.9.4 OTHERS

12.1 NORTH AMERICA LIFE SCIENCES & RESEARCH ORGANIZATIONS IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

12.10.1 NORTH AMERICA

12.10.2 EUROPE

12.10.3 ASIA-PACIFIC

12.10.4 SOUTH AMERICA

12.10.5 MIDDLE EAST & AFRICA

12.11 NORTH AMERICA PHARMACIES & PHARMACY NETWORKS IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

12.11.1 RETAIL PHARMACIES

12.11.2 HOSPITAL PHARMACIES

12.11.3 E-PHARMACY PLATFORMS

12.11.4 OTHERS

12.12 NORTH AMERICA PHARMACIES & PHARMACY NETWORKS IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

12.12.1 NORTH AMERICA

12.12.2 EUROPE

12.12.3 ASIA-PACIFIC

12.12.4 SOUTH AMERICA

12.12.5 MIDDLE EAST & AFRICA

12.13 NORTH AMERICA PATIENTS & CONSUMER HEALTH PLATFORMS IN INTEROPERABILITY MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

12.13.1 PATIENT PORTALS

12.13.2 PERSONAL HEALTH RECORD (PHR) PLATFORMS

12.13.3 OTHERS

12.14 NORTH AMERICA PATIENTS & CONSUMER HEALTH PLATFORMS IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

12.14.1 NORTH AMERICA

12.14.2 EUROPE

12.14.3 ASIA-PACIFIC

12.14.4 SOUTH AMERICA

12.14.5 MIDDLE EAST & AFRICA

12.15 NORTH AMERICA OTHERS IN INTEROPERABILITY MARKET, BY REGION, 2018-2033 (USD THOUSAND)

12.15.1 NORTH AMERICA

12.15.2 EUROPE

12.15.3 ASIA-PACIFIC

12.15.4 SOUTH AMERICA

12.15.5 MIDDLE EAST & AFRICA

13 NORTH AMERICA INTEROPERABILITY MARKET, BY REGION

13.1 NORTH AMERICA

13.1.1 U.S.

13.1.2 CANADA

13.1.3 MEXICO

14 NORTH AMERICA INTEROPERABILITY MARKET: COMPANY LANDSCAPE

14.1 MANUFACTURER COMPANY SHARE ANALYSIS: GLOBAL

15 SWOT ANALYSIS

16 COMPANY PROFILES

16.1 MICROSOFT

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENT

16.2 ORACLE

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENT

16.3 EPIC SYSTEMS CORPORATION

16.3.1 COMPANY SNAPSHOT

16.3.2 COMPANY SHARE ANALYSIS

16.3.3 PRODUCT PORTFOLIO

16.3.4 RECENT DEVELOPMENT

16.4 INTERSYSTEMS CORPORATION

16.4.1 COMPANY SNAPSHOT

16.4.2 COMPANY SHARE ANALYSIS

16.4.3 PRODUCT PORTFOLIO

16.4.4 RECENT DEVELOPMENT

16.5 ATHENAHEALTH

16.5.1 COMPANY SNAPSHOT

16.5.2 COMPANY SHARE ANALYSIS

16.5.3 PRODUCT PORTFOLIO

16.5.4 RECENT DEVELOPMENT

16.6 AIGILX HEALTH

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENT

16.7 AMAZON WEB SERVICES (AWS).

16.7.1 COMPANY SNAPSHOT

16.7.2 REVENUE ANALYSIS

16.7.3 PRODUCT PORTFOLIO

16.7.4 RECENT DEVELOPMENT

16.8 CITIUSTECH INC

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENT

16.9 CLEARDATA

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENT

16.1 GE HEALTHCARE

16.10.1 COMPANY SNAPSHOT

16.10.2 REVENUE ANALYSIS

16.10.3 PRODUCT PORTFOLIO

16.10.4 RECENT DEVELOPMENT

16.11 GOOGLE LLC.

16.11.1 COMPANY SNAPSHOT

16.11.2 REVENUE ANALYSIS

16.11.3 PRODUCT PORTFOLIO

16.11.4 RECENT DEVELOPMENT

16.12 HEALTH CATALYST

16.12.1 COMPANY SNAPSHOT

16.12.2 REVENUE ANALYSIS

16.12.3 PRODUCT PORTFOLIO

16.12.4 RECENT DEVELOPMENT

16.13 HEALTH GORILLA

16.13.1 COMPANY SNAPSHOT

16.13.2 PRODUCT PORTFOLIO

16.13.3 RECENT DEVELOPMENT

16.14 IBM.

16.14.1 COMPANY SNAPSHOT

16.14.2 REVENUE ANALYSIS

16.14.3 PRODUCT PORTFOLIO

16.14.4 RECENT DEVELOPMENT

16.15 INTERFACEWARE INC.

16.15.1 COMPANY SNAPSHOT

16.15.2 PRODUCT PORTFOLIO

16.15.3 RECENT DEVELOPMENT

16.16 KOCH IP HOLDINGS, LLC

16.16.1 COMPANY SNAPSHOT

16.16.2 PRODUCT PORTFOLIO

16.16.3 RECENT DEVELOPMENT

16.17 KONINKLIJKE PHILIPS N.V.

16.17.1 COMPANY SNAPSHOT

16.17.2 REVENUE ANALYSIS

16.17.3 PRODUCT PORTFOLIO

16.17.4 RECENT DEVELOPMENT

16.18 MCKESSON CORPORATION.

16.18.1 COMPANY SNAPSHOT

16.18.2 REVENUE ANALYSIS

16.18.3 PRODUCT PORTFOLIO

16.18.4 RECENT DEVELOPMENT

16.19 MEDICAL INFORMATION TECHNOLOGY, INC.

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENT

16.2 NXGN MANAGEMENT, LLC

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENT

16.21 ORION HEALTH

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENT

16.22 OSP

16.22.1 COMPANY SNAPSHOT

16.22.2 PRODUCT PORTFOLIO

16.22.3 RECENT DEVELOPMENT

16.23 RHAPSODY

16.23.1 COMPANY SNAPSHOT

16.23.2 PRODUCT PORTFOLIO

16.23.3 RECENT DEVELOPMENT

16.24 SIEMENS HEALTHINEERS AG.

16.24.1 COMPANY SNAPSHOT

16.24.2 REVENUE ANALYSIS

16.24.3 PRODUCT PORTFOLIO

16.24.4 RECENT DEVELOPMENT

16.25 SMILE CDR INC.

16.25.1 COMPANY SNAPSHOT

16.25.2 PRODUCT PORTFOLIO

16.25.3 RECENT DEVELOPMENT

16.26 SURESCRIPTS

16.26.1 COMPANY SNAPSHOT

16.26.2 PRODUCT PORTFOLIO

16.26.3 RECENT DEVELOPMENT

16.27 TRINETX, LLC

16.27.1 COMPANY SNAPSHOT

16.27.2 PRODUCT PORTFOLIO

16.27.3 RECENT DEVELOPMENT

16.28 VERADIGM LLC

16.28.1 COMPANY SNAPSHOT

16.28.2 PRODUCT PORTFOLIO

16.28.3 RECENT DEVELOPMENT

16.29 VERATO

16.29.1 COMPANY SNAPSHOT

16.29.2 PRODUCT PORTFOLIO

16.29.3 RECENT DEVELOPMENT

16.3 1UPHEALTH, INC.

16.30.1 COMPANY SNAPSHOT

16.30.2 PRODUCT PORTFOLIO

16.30.3 RECENT DEVELOPMENT

17 QUESTIONNAIRE

18 RELATED REPORTS